In addition, only one study focused on the association between SNHG12 expression and recurrence-free survival (RFS), which suggested that increased SNHG12 expression was strongly associated with poor RFS in HCC [21]. This evidence concerns the gene SNHG12 and hepatocellular carcinoma.